Sunesis Pharmaceuticals (SNSS) Lost 15c/Share in Q4
Tweet Send to a Friend
Sunesis Pharmaceuticals (Nasdaq: SNSS) reported Q4 EPS of ($0.15), $0.05 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
